DZ Bank
UTMD icon

DZ Bank’s Utah Medical Products UTMD Stock Holding History

DZ Bank’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,201
Closed -$95.9K – 911
2020
Q3 		$95.9K Hold
1,201
– – ﹤0.01% 750
2020
Q2 		$106K Sell
1,201
-1,111
-48% -$99.7K ﹤0.01% 721
2020
Q1 		$217K Sell
2,312
-20,335
-90% -$1.89M ﹤0.01% 650
2019
Q4 		$2.44M Hold
22,647
– – 0.01% 456
2019
Q3 		$2.17M Buy
22,647
+11,332
+100% +$1.05M 0.01% 455
2019
Q2 		$1.08M Buy
11,315
+9,340
+473% +$786K ﹤0.01% 550
2019
Q1 		$174K Hold
1,975
– – ﹤0.01% 674
2018
Q4 		$161K Buy
+1,975
New +$174K ﹤0.01% 672

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DZ Bank's UTMD Position: Q4 2020 in Review

DZ Bank sold out of Utah Medical Products (UTMD) in Q4 2020, closing a stake of 1,201 shares — an estimated $95.9K sold.

DZ Bank first reported a position in UTMD in Q4 2018 and held it in 8 quarters. The position peaked at $2.44M in Q4 2019. 77 funds tracked by Wall St. Rank hold UTMD as of Q4 2020.

  • DZ Bank reported no remaining Utah Medical Products position as of Q4 2020 after selling out during the quarter.
  • DZ Bank sold 1,201 Utah Medical Products shares in Q4 2020, an estimated $95.9K.
  • DZ Bank first reported a position in Utah Medical Products in Q4 2018 and held it in 8 quarters.
  • DZ Bank's Utah Medical Products position peaked at $2.44M in Q4 2019.
  • 77 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2020.

Based on DZ Bank's 13F filing for Q4 2020, filed 16 Feb 2021.